The Liver Meeting 2019-Debate (CON): HCV+ Donation Is No Longer Research and Is Ready to Move to Standard of Care

Debate (CON): HCV+ Donation Is No Longer Research and Is Ready to Move to Standard of Care

Video Transcription

Video Summary

In the video panel discussion, experts focused on the debate surrounding the use of HIV-infected organs for transplantation, emphasizing the need for further research to guide best practices. Key points included the lack of established policies and regulations governing this practice, the importance of collecting well-controlled data through research to determine standards of care, and the risks associated with de novo HCV transmission via organ transplant. The panel also discussed the challenges in determining treatment lengths, recipient and donor selection, and minimizing exposure to viremia. There was a call for a randomized control trial, particularly in kidney transplantation, to compare prevention approaches to transmit and treat protocols. Overall, the panel stressed the need for more data to inform clinical practices and justify payer coverage, highlighting the importance of research in this evolving field.

Asset Caption

Presenter: Susanna Naggie

Keywords

HIV-infected organs transplantation

research

policies and regulations

de novo HCV transmission

organ transplant risks

randomized control trial